ArticleIn vivo (Athens, Greece)

Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure.

Tomoaki Nishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.